{"transactions":[{"id":4616288,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-11T22:11:50.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3283,"price":5.81,"value":19074.23,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":432916,"source":{"system":"sec-edgar","filing":"0001104659-26-107143","document":"tm2625275-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926107143/tm2625275-1_4seq1.xml","form_type":"4"}},{"id":4616287,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-09-11T22:11:50.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3283,"price":5.81,"value":19074.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":1067463,"source":{"system":"sec-edgar","filing":"0001104659-26-107143","document":"tm2625275-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926107143/tm2625275-1_4seq1.xml","form_type":"4"}},{"id":3272009,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-09-08T12:15:06.000Z","date":"2026-09-03","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.79,"value":47900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.73 to $4.79. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1070746,"source":{"system":"sec-edgar","filing":"0001104659-26-105690","document":"tm2624891-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926105690/tm2624891-1_4seq1.xml","form_type":"4"}},{"id":740062,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-12T20:15:17.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3283,"price":4.02,"value":13197.66,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":436199,"source":{"system":"sec-edgar","filing":"0001104659-26-073468","document":"tm2617747-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926073468/tm2617747-1_4seq1.xml","form_type":"4"}},{"id":740061,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-06-12T20:15:17.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3283,"price":4.02,"value":13197.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":1060746,"source":{"system":"sec-edgar","filing":"0001104659-26-073468","document":"tm2617747-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926073468/tm2617747-1_4seq1.xml","form_type":"4"}},{"id":754999,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-06-02T20:28:57.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.83,"value":19150.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $3.91. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1064029,"source":{"system":"sec-edgar","filing":"0001104659-26-069510","document":"tm2616712-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926069510/tm2616712-2_4seq1.xml","form_type":"4"}},{"id":772215,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-05-19T12:00:07.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.77,"value":18850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.75 to $3.79. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1059029,"source":{"system":"sec-edgar","filing":"0001104659-26-063510","document":"tm2614983-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926063510/tm2614983-2_4seq1.xml","form_type":"4"}},{"id":826422,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-03-27T20:30:17.000Z","date":"2026-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":32438,"price":4.57,"value":148241.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units (\"RSUs\"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations."}],"balance_after":1054029,"source":{"system":"sec-edgar","filing":"0001104659-26-036162","document":"tm269936-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926036162/tm269936-1_4seq1.xml","form_type":"4"}},{"id":841726,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-03-16T20:54:18.000Z","date":"2026-03-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.29,"value":42900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.30. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1086467,"source":{"system":"sec-edgar","filing":"0001104659-26-028554","document":"tm268956-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926028554/tm268956-1_4seq1.xml","form_type":"4"}},{"id":905339,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2026-02-13T22:00:30.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":504000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 25% of the shares will vest 18 months after February 12, 2026 (the \"Issue Date\"), (ii) 25% of the shares will vest 24 months after the Issue Date, (iii) 25% of the shares will vest 30 months after the Issue Date and (iv) 25% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":1076467,"source":{"system":"sec-edgar","filing":"0001104659-26-015318","document":"tm266316-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926015318/tm266316-1_4seq1.xml","form_type":"4"}},{"id":971311,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-12T21:15:15.000Z","date":"2025-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3283,"price":4.67,"value":15331.61,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":439482,"source":{"system":"sec-edgar","filing":"0001104659-25-120659","document":"tm2533361-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925120659/tm2533361-1_4seq1.xml","form_type":"4"}},{"id":971310,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-12-12T21:15:15.000Z","date":"2025-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":40355,"price":4.67,"value":188457.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":572467,"source":{"system":"sec-edgar","filing":"0001104659-25-120659","document":"tm2533361-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925120659/tm2533361-1_4seq1.xml","form_type":"4"}},{"id":997875,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-11-17T22:00:21.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.07,"value":20350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.06 to $4.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":612822,"source":{"system":"sec-edgar","filing":"0001104659-25-113235","document":"tm2531478-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925113235/tm2531478-1_4seq1.xml","form_type":"4"}},{"id":998948,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-14T22:00:13.000Z","date":"2025-11-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":3283,"price":4.18,"value":13722.94,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":442765,"source":{"system":"sec-edgar","filing":"0001104659-25-112699","document":"tm2531368-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925112699/tm2531368-1_4seq1.xml","form_type":"4"}},{"id":998947,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-11-14T22:00:13.000Z","date":"2025-11-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":3283,"price":4.18,"value":13722.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":607822,"source":{"system":"sec-edgar","filing":"0001104659-25-112699","document":"tm2531368-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925112699/tm2531368-1_4seq1.xml","form_type":"4"}},{"id":1035631,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-19T21:30:07.000Z","date":"2025-09-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":3283,"price":2.46,"value":8076.18,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":446048,"source":{"system":"sec-edgar","filing":"0001104659-25-091742","document":"tm2526559-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925091742/tm2526559-1_4seq1.xml","form_type":"4"}},{"id":1035630,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-09-19T21:30:07.000Z","date":"2025-09-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":40355,"price":2.46,"value":99273.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":611105,"source":{"system":"sec-edgar","filing":"0001104659-25-091742","document":"tm2526559-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925091742/tm2526559-1_4seq1.xml","form_type":"4"}},{"id":1056861,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-08-25T23:03:18.000Z","date":"2025-08-21","kind":"purchase","planned":false,"acquired":true,"shares":6000,"price":2.49,"value":14940.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.49 to $2.50. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":651460,"source":{"system":"sec-edgar","filing":"0001104659-25-082635","document":"tm2524324-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925082635/tm2524324-2_4seq1.xml","form_type":"4"}},{"id":1071427,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-08T23:11:32.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") to the Reporting Person on August 7, 2025 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after the Grant Date, (ii) 33.33% of the shares will vest 30 months after the Grant Date, and (iii) 33.34% of the shares will vest 36 months after the Grant Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":449331,"source":{"system":"sec-edgar","filing":"0001104659-25-075782","document":"tm2523004-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925075782/tm2523004-3_4seq1.xml","form_type":"4"}},{"id":1071426,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-08-08T23:11:32.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") to the Reporting Person on August 7, 2025 (the \"Grant Date\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after the Grant Date, (ii) 33.33% of the shares will vest 30 months after the Grant Date, and (iii) 33.34% of the shares will vest 36 months after the Grant Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":645460,"source":{"system":"sec-edgar","filing":"0001104659-25-075782","document":"tm2523004-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925075782/tm2523004-3_4seq1.xml","form_type":"4"}},{"id":1076367,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-08-04T22:16:12.000Z","date":"2025-08-04","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.75,"value":55000.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $2.75 per share."}],"balance_after":349331,"source":{"system":"sec-edgar","filing":"0001104659-25-073743","document":"tm2522548-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925073743/tm2522548-1_4seq1.xml","form_type":"4"}},{"id":1111849,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-13T20:41:57.000Z","date":"2025-06-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":5671,"price":3.14,"value":17806.94,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":329331,"source":{"system":"sec-edgar","filing":"0001104659-25-059416","document":"tm2517997-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925059416/tm2517997-1_4seq1.xml","form_type":"4"}},{"id":1111848,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-06-13T20:41:57.000Z","date":"2025-06-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":34038,"price":3.14,"value":106879.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":545460,"source":{"system":"sec-edgar","filing":"0001104659-25-059416","document":"tm2517997-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925059416/tm2517997-1_4seq1.xml","form_type":"4"}},{"id":1177726,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-05T01:44:39.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":147500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest as follows: (i) 36,875 of the stock options will vest on April 4, 2026 (the \"Vesting Commencement Date\") and (ii) the remaining 110,625 stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on July 4, 2026, subject to the Reporting Person's continuous service through such dates."}],"balance_after":147500,"derivative":{"exercise_price":2.76,"expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":147500},"source":{"system":"sec-edgar","filing":"0001104659-25-032334","document":"tm2511637-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925032334/tm2511637-3_4seq1.xml","form_type":"4"}},{"id":1177725,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-04-05T01:44:39.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":98333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after April 4, 2025 (the \"Issue Date\"), (ii) 33.33% of the shares will vest 30 months after the Issue Date, and (iii) 33.34% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":579498,"source":{"system":"sec-edgar","filing":"0001104659-25-032334","document":"tm2511637-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925032334/tm2511637-3_4seq1.xml","form_type":"4"}},{"id":1217555,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2025-03-08T00:32:47.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":80080,"price":4.23,"value":338738.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations."}],"balance_after":499418,"source":{"system":"sec-edgar","filing":"0001104659-25-021856","document":"tm258652-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465925021856/tm258652-1_4seq1.xml","form_type":"4"}},{"id":1321750,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-12-26T22:46:42.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":4.66,"value":18640.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.60 to $4.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":579498,"source":{"system":"sec-edgar","filing":"0001104659-24-131767","document":"tm2431687-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924131767/tm2431687-2_4seq1.xml","form_type":"4"}},{"id":1325479,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-12-19T13:30:09.000Z","date":"2024-12-18","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.91,"value":24550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.88 to $4.94. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":575498,"source":{"system":"sec-edgar","filing":"0001104659-24-130007","document":"tm2431550-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924130007/tm2431550-1_4seq1.xml","form_type":"4"}},{"id":1399005,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-26T12:15:12.000Z","date":"2024-09-25","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.73,"value":9460.0,"ownership":{"direct":false,"nature":"By the Judah Herman Hochman 2019 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001104659-24-103002","document":"tm2425000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924103002/tm2425000-1_4seq1.xml","form_type":"4"}},{"id":1399004,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-26T12:15:12.000Z","date":"2024-09-25","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.7,"value":9400.0,"ownership":{"direct":false,"nature":"By the Hannah Hochman 2019 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.68 to $4.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001104659-24-103002","document":"tm2425000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924103002/tm2425000-1_4seq1.xml","form_type":"4"}},{"id":1399003,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-26T12:15:12.000Z","date":"2024-09-25","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.74,"value":9480.0,"ownership":{"direct":false,"nature":"By the Solomon Ascher Hochman 2019 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.72 to $4.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001104659-24-103002","document":"tm2425000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924103002/tm2425000-1_4seq1.xml","form_type":"4"}},{"id":1399002,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-26T12:15:12.000Z","date":"2024-09-25","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":4.86,"value":7290.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.83 to $4.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":335002,"source":{"system":"sec-edgar","filing":"0001104659-24-103002","document":"tm2425000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924103002/tm2425000-1_4seq1.xml","form_type":"4"}},{"id":1399001,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-09-26T12:15:12.000Z","date":"2024-09-24","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":4.91,"value":12275.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $4.95. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":570498,"source":{"system":"sec-edgar","filing":"0001104659-24-103002","document":"tm2425000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924103002/tm2425000-1_4seq1.xml","form_type":"4"}},{"id":1432614,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-08-15T21:30:54.000Z","date":"2024-08-14","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":5.84,"value":14600.0,"ownership":{"direct":true},"balance_after":567998,"source":{"system":"sec-edgar","filing":"0001104659-24-090181","document":"tm2421778-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924090181/tm2421778-1_4seq1.xml","form_type":"4"}},{"id":1468785,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-06-26T20:15:13.000Z","date":"2024-06-25","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.95,"value":6950.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"balance_after":333502,"source":{"system":"sec-edgar","filing":"0001104659-24-075169","document":"tm2418333-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924075169/tm2418333-1_4seq1.xml","form_type":"4"}},{"id":1507277,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-22T01:15:57.000Z","date":"2024-05-17","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":5.15,"value":15450.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On May 20, 2024, the Reporting Person filed a Form 4 which inadvertently misstated the transaction codes in Column 3 of Table I. This amendment is filed solely to correct the transaction codes in Column 3 of Table I to \"P\". The remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.92 to $5.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":332502,"source":{"system":"sec-edgar","filing":"0001104659-24-064004","document":"tm2415131-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924064004/tm2415131-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-20"}},{"id":1507276,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-05-22T01:15:57.000Z","date":"2024-05-16","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":4.75,"value":9500.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On May 20, 2024, the Reporting Person filed a Form 4 which inadvertently misstated the transaction codes in Column 3 of Table I. This amendment is filed solely to correct the transaction codes in Column 3 of Table I to \"P\". The remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":329502,"source":{"system":"sec-edgar","filing":"0001104659-24-064004","document":"tm2415131-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924064004/tm2415131-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2024-05-20"}},{"id":1509090,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-20T20:15:27.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":5.15,"value":15450.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.92 to $5.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":332502,"source":{"system":"sec-edgar","filing":"0001104659-24-063414","document":"tm2414952-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924063414/tm2414952-1_4seq1.xml","form_type":"4"}},{"id":1509089,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-05-20T20:15:27.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":4.75,"value":9500.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.74 to $4.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":329502,"source":{"system":"sec-edgar","filing":"0001104659-24-063414","document":"tm2414952-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924063414/tm2414952-1_4seq1.xml","form_type":"4"}},{"id":1520869,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-10T21:22:52.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 15,000 RSUs will vest on June 10, 2025, and (ii) the remaining 85,000 RSUs will vest in equal installments on September 10, 2025, November 10, 2025, December 10, 2025, June 10, 2026, September 10, 2026, December 10, 2026, March 22, 2027, June 10, 2027, September 10, 2027, December 10, 2027, March 22, 2028 and June 10, 2028, subject to the Reporting Person's continuous service through such dates."}],"balance_after":327502,"source":{"system":"sec-edgar","filing":"0001104659-24-060001","document":"tm2414108-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924060001/tm2414108-4_4seq1.xml","form_type":"4"}},{"id":1520868,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2024-05-10T21:22:52.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 15,000 RSUs will vest on June 10, 2025, and (ii) the remaining 85,000 RSUs will vest in equal installments on September 10, 2025, November 10, 2025, December 10, 2025, June 10, 2026, September 10, 2026, December 10, 2026, March 22, 2027, June 10, 2027, September 10, 2027, December 10, 2027, March 22, 2028 and June 10, 2028, subject to the Reporting Person's continuous service through such dates."}],"balance_after":565498,"source":{"system":"sec-edgar","filing":"0001104659-24-060001","document":"tm2414108-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465924060001/tm2414108-4_4seq1.xml","form_type":"4"}},{"id":1824235,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-24T21:13:27.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":132000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest over a four-year period as follows: (i) 25% of the underlying shares will vest on the one-year anniversary of the Vesting Commencement Date and (ii) 75% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting on the last day of the first quarter after the first anniversary of the Vesting Commencement Date, or March 31, 2024, subject to the Reporting Person's continuous service through such dates."}],"balance_after":132000,"derivative":{"exercise_price":7.42,"expiration_date":"2033-07-20","underlying":"Common Stock","underlying_shares":132000},"source":{"system":"sec-edgar","filing":"0001104659-23-083505","document":"tm2321855-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923083505/tm2321855-10_4seq1.xml","form_type":"4"}},{"id":1824234,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-24T21:13:27.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":100500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest over a four-year period as follows: (i) 25% of the underlying shares will vest on the one-year anniversary of the Vesting Commencement Date and (ii) 75% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting on the last day of the first quarter after the first anniversary of the Vesting Commencement Date, or March 31, 2024, subject to the Reporting Person's continuous service through such dates."}],"balance_after":100500,"derivative":{"exercise_price":7.42,"expiration_date":"2033-07-20","underlying":"Common Stock","underlying_shares":100500},"source":{"system":"sec-edgar","filing":"0001104659-23-083505","document":"tm2321855-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923083505/tm2321855-10_4seq1.xml","form_type":"4"}},{"id":1824233,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-24T21:13:27.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of January 26, 2023 (the \"Vesting Commencement Date\"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":227502,"source":{"system":"sec-edgar","filing":"0001104659-23-083505","document":"tm2321855-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923083505/tm2321855-10_4seq1.xml","form_type":"4"}},{"id":1824232,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-07-24T21:13:27.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 34% of the shares will vest on the 18-month anniversary of January 26, 2023 (the \"Vesting Commencement Date\"), (ii) 33% the shares will vest on the two-year anniversary of the Vesting Commencement Date, and (iii) 33% the shares will vest on the three-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service through such dates."}],"balance_after":465498,"source":{"system":"sec-edgar","filing":"0001104659-23-083505","document":"tm2321855-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465923083505/tm2321855-10_4seq1.xml","form_type":"4"}},{"id":1884806,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-05-19T21:51:42.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":116250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration dates of three classes of nonstatutory stock options (\"NSOs\") and (ii) misstated the vesting schedules for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration dates in Table II, Column 6 to August 17, 2032, August 17, 2032 and January 19, 2033, respectively, and (ii) correct the incorrect vesting schedules set forth in the footnotes corresponding to such NSOs, which are reproduced in this amendment with the correct vesting schedules; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 250,000 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The NSOs vest over a three-year period as follows: (i) 44.4% of the underlying shares vested on the grant date and (ii) 55.6% of the underlying shares will vest in equal installments on a quarterly basis on the last day of each quarter, starting with March 31, 2023, subject to the Reporting Person's continuous service through such dates. The grant date is January 20, 2023."}],"balance_after":116250,"derivative":{"exercise_price":10,"expiration_date":"2033-01-19","underlying":"Common Stock","underlying_shares":116250},"source":{"system":"sec-edgar","filing":"0001213900-23-041627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023041627/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1884805,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-05-19T21:51:42.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":208216,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration dates of three classes of nonstatutory stock options (\"NSOs\") and (ii) misstated the vesting schedules for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration dates in Table II, Column 6 to August 17, 2032, August 17, 2032 and January 19, 2033, respectively, and (ii) correct the incorrect vesting schedules set forth in the footnotes corresponding to such NSOs, which are reproduced in this amendment with the correct vesting schedules; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 447,776 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with September 30, 2022, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022."}],"balance_after":208216,"derivative":{"exercise_price":10,"expiration_date":"2032-08-17","underlying":"Common Stock","underlying_shares":208216},"source":{"system":"sec-edgar","filing":"0001213900-23-041627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023041627/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1884804,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-05-19T21:51:42.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":300181,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently (i) misstated the expiration dates of three classes of nonstatutory stock options (\"NSOs\") and (ii) misstated the vesting schedules for such NSOs. In accordance with Instruction 9(b) to Form 4, this amendment is filed solely to (i) correct the incorrect expiration dates in Table II, Column 6 to August 17, 2032, August 17, 2032 and January 19, 2033, respectively, and (ii) correct the incorrect vesting schedules set forth in the footnotes corresponding to such NSOs, which are reproduced in this amendment with the correct vesting schedules; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 645,551 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with September 30, 2022, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022."}],"balance_after":300181,"derivative":{"exercise_price":10,"expiration_date":"2032-08-17","underlying":"Common Stock","underlying_shares":300181},"source":{"system":"sec-edgar","filing":"0001213900-23-041627","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023041627/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1902969,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-06T00:08:56.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":1366,"ownership":{"direct":false,"nature":"By the NSH 2008 Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently omitted the right to receive Earnout Shares (defined below). In accordance with Instruction 9(a) to Form 4, this amendment is filed solely to add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."}],"balance_after":1366,"derivative":{"underlying":"Common Stock","underlying_shares":1366},"source":{"system":"sec-edgar","filing":"0001213900-23-037012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037012/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1902968,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-06T00:08:56.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":22320,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently omitted the right to receive Earnout Shares (defined below). In accordance with Instruction 9(a) to Form 4, this amendment is filed solely to add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."}],"balance_after":22320,"derivative":{"underlying":"Common Stock","underlying_shares":22320},"source":{"system":"sec-edgar","filing":"0001213900-23-037012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037012/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1902967,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-06T00:08:56.000Z","date":"2023-01-26","kind":"grant","planned":false,"acquired":true,"shares":59102,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On January 30, 2023, the Reporting Person filed a Form 4 which inadvertently omitted the right to receive Earnout Shares (defined below). In accordance with Instruction 9(a) to Form 4, this amendment is filed solely to add the lines of information to Table II included here; as provided in that instruction, the remainder of the information in the original filing is not restated in this amendment, and no other amendment is made to the original filing."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."}],"balance_after":59102,"derivative":{"underlying":"Common Stock","underlying_shares":59102},"source":{"system":"sec-edgar","filing":"0001213900-23-037012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037012/ownership.xml","form_type":"4/A","original_submission_date":"2023-01-30"}},{"id":1902962,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-05T23:39:42.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":false,"shares":683,"ownership":{"direct":false,"nature":"By the NSH 2008 Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":683,"derivative":{"underlying":"Common Stock","underlying_shares":683},"source":{"system":"sec-edgar","filing":"0001213900-23-037001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037001/ownership.xml","form_type":"4"}},{"id":1902961,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-05T23:39:42.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":false,"shares":11160,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":11160,"derivative":{"underlying":"Common Stock","underlying_shares":11160},"source":{"system":"sec-edgar","filing":"0001213900-23-037001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037001/ownership.xml","form_type":"4"}},{"id":1902960,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Right to Receive Earnout Shares","published_at":"2023-05-05T23:39:42.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":false,"shares":29551,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":29551,"derivative":{"underlying":"Common Stock","underlying_shares":29551},"source":{"system":"sec-edgar","filing":"0001213900-23-037001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037001/ownership.xml","form_type":"4"}},{"id":1902959,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-05T23:39:42.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":true,"shares":683,"ownership":{"direct":false,"nature":"By the NSH 2008 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":3823,"source":{"system":"sec-edgar","filing":"0001213900-23-037001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037001/ownership.xml","form_type":"4"}},{"id":1902958,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-05T23:39:42.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":true,"shares":11160,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":62502,"source":{"system":"sec-edgar","filing":"0001213900-23-037001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037001/ownership.xml","form_type":"4"}},{"id":1902957,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-05-05T23:39:42.000Z","date":"2023-04-12","kind":"exercise","planned":false,"acquired":true,"shares":29551,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of July 4, 2022 (and as subsequently amended) by and among the Issuer and certain other parties named therein (the \"Merger Agreement\"), the Reporting Person has the contingent right to receive, for no additional consideration, the Reporting Person's Pro Rata Portion (as such term is defined in the Merger Agreement ) of 8,000,000 shares of common stock of the Issuer (the \"Earnout Shares\") if, at any time from January 26, 2023 until January 26, 2028, the volume-weighted average price of the common stock of the Issuer is greater than or equal to (i) with respect to 4,000,000 Earnout Shares, $15.00 per share over any 20 trading days within any 30-trading day period (the \"Initial Milestone Event\") and (ii) with respect to 4,000,000 Earnout Shares, $20.00 per share over any 20 trading days within any 30-trading day period."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Initial Milestone Event occurred on April 12, 2023 and 29,551 shares of Common Stock, 11,160 shares of Common Stock and 683 shares of Common Stock were issued to David P. Hochman, the DPH 2008 Trust and the NSH 2008 Family Trust, respectively, on April 19, 2023 in accordance with the Merger Agreement."}],"balance_after":165498,"source":{"system":"sec-edgar","filing":"0001213900-23-037001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023037001/ownership.xml","form_type":"4"}},{"id":2042298,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrant (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":410,"ownership":{"direct":false,"nature":"By the NSH 2008 Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Received in the Business Combination in exchange for warrants to purchase 881 shares of Legacy Orchestra Common Stock for $10.00 per share."}],"balance_after":410,"derivative":{"exercise_price":21.51,"exercise_date":"2023-01-26","expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":410},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042297,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrant (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":422,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Received in the Business Combination in exchange for warrants to purchase 907 shares of Legacy Orchestra Common Stock for $10.00 per share."}],"balance_after":422,"derivative":{"exercise_price":21.51,"exercise_date":"2023-01-26","expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":422},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042296,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":6743,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Received in the Business Combination in exchange for an incentive stock option to acquire 14,500 shares of Legacy Orchestra Common Stock for $1.89 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The incentive stock options vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is April 12, 2022."}],"balance_after":6743,"derivative":{"exercise_price":4.06,"expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":6743},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042295,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":69750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Received in the Business Combination in exchange for an incentive stock option to acquire 150,000 shares of Legacy Orchestra Common Stock for $2.00 per share."}],"balance_after":69750,"derivative":{"exercise_price":4.3,"exercise_date":"2023-01-26","expiration_date":"2028-08-07","underlying":"Common Stock","underlying_shares":69750},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042294,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":116250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 250,000 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is January 20, 2023."}],"balance_after":116250,"derivative":{"exercise_price":10,"expiration_date":"2023-01-19","underlying":"Common Stock","underlying_shares":116250},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042293,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":208216,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 447,776 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022."}],"balance_after":208216,"derivative":{"exercise_price":10,"expiration_date":"2032-08-25","underlying":"Common Stock","underlying_shares":208216},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042292,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":300181,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 645,551 shares of Legacy Orchestra Common Stock for $4.65 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The NSOs vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is August 18, 2022."}],"balance_after":300181,"derivative":{"exercise_price":10,"expiration_date":"2032-08-25","underlying":"Common Stock","underlying_shares":300181},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042291,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":31000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 66,667 shares of Legacy Orchestra Common Stock for $1.89 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The nonstatutory stock options (\"NSOs\") vest over a three-year period as follows: (i) 33% of the underlying shares vested on the grant date and (ii) 67% of the underlying shares have vested and will vest in equal installments on a quarterly basis on the last day of each quarter, starting with the end of the first quarter after the grant date, subject to the Reporting Person's continuous service through such dates. The grant date is April 12, 2022."}],"balance_after":31000,"derivative":{"exercise_price":4.06,"expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042290,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Nonstatutory Stock Option (Right to Buy)","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":194071,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Business Combination in exchange for a nonstatutory stock option to acquire 417,357 shares of Legacy Orchestra Common Stock for $2.00 per share."}],"balance_after":194071,"derivative":{"exercise_price":4.3,"exercise_date":"2023-01-26","expiration_date":"2028-08-07","underlying":"Common Stock","underlying_shares":194071},"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042289,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":3140,"ownership":{"direct":false,"nature":"By the NSH 2008 Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued on the closing date of the merger (the \"Business Combination\") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the \"Merger Agreement\"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) (\"HSAC2\"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation (\"Legacy Orchestra\"), in exchange for Legacy Orchestra securities."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Business Combination in exchange for 6,753 shares of common stock of Legacy Orchestra Common Stock."}],"balance_after":3140,"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042288,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":51342,"ownership":{"direct":false,"nature":"By the DPH 2008 Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued on the closing date of the merger (the \"Business Combination\") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the \"Merger Agreement\"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) (\"HSAC2\"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation (\"Legacy Orchestra\"), in exchange for Legacy Orchestra securities."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Business Combination in exchange for 110,412 shares of common stock of Legacy Orchestra Common Stock."}],"balance_after":51342,"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2042287,"issuer":{"id":434,"kind":"organization","name":"Orchestra BioMed Holdings, Inc.","symbol":"OBIO"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock, par value $0.0001 per share (\"Common Stock\")","published_at":"2023-01-31T02:26:36.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":135947,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued on the closing date of the merger (the \"Business Combination\") contemplated by the Agreement and Plan of Merger, dated as of July 4, 2022, as amended by Amendment No. 1 thereto dated as of July 21, 2022 and Amendment No. 2 thereto dated as of November 21, 2022 (as amended, the \"Merger Agreement\"), by and among Orchestra BioMed Holdings, Inc. (f/k/a Health Sciences Acquisitions Corporation 2) (\"HSAC2\"), HSAC Olympus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HSAC2, and Orchestra BioMed, Inc., a Delaware corporation (\"Legacy Orchestra\"), in exchange for Legacy Orchestra securities."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in the Business Combination in exchange for 292,360 shares of common stock of Legacy Orchestra (\"Legacy Orchestra Common Stock\")."}],"balance_after":135947,"source":{"system":"sec-edgar","filing":"0001213900-23-006179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023006179/ownership.xml","form_type":"4"}},{"id":2401681,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T17:09:15.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\"). The option becomes exercisable as to 100% of the shares on February 10, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":50000,"derivative":{"exercise_price":0.46,"expiration_date":"2032-02-10","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-004060","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315222004060/ownership.xml","form_type":"4"}},{"id":2440045,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-01-07T16:45:29.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":127083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 5, 2022, Reporting Person was granted 127,083 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2022, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":291669,"source":{"system":"sec-edgar","filing":"0001493152-22-000694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000149315222000694/ownership.xml","form_type":"4"}},{"id":2846316,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-19T16:15:43.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 100% of the shares on February 17, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":40000,"derivative":{"exercise_price":1.78,"expiration_date":"2031-02-17","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-21-010577","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010577/ownership.xml","form_type":"4"}},{"id":2846315,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-02-19T16:15:43.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":32472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"On February 17, 2021, Reporting Person was granted 32,472 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2021, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":164586,"source":{"system":"sec-edgar","filing":"0001213900-21-010577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010577/ownership.xml","form_type":"4"}},{"id":2846314,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-02-19T16:15:43.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 17, 2021, Reporting Person was granted 40,000 Common Stock restricted stock units. The restricted stock units vest as to 100% of the shares on February 17, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":132114,"source":{"system":"sec-edgar","filing":"0001213900-21-010577","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021010577/ownership.xml","form_type":"4"}},{"id":2907235,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-01-14T09:00:40.000Z","date":"2021-01-12","kind":"grant","acquired":true,"shares":15741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 12, 2021, Reporting Person was granted 15,741 shares of Common Stock as compensation for Reporting Persons service as a director during the fourth quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":92114,"source":{"system":"sec-edgar","filing":"0001213900-21-002116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390021002116/ownership.xml","form_type":"4"}},{"id":2955237,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-12-07T09:00:22.000Z","date":"2020-12-04","kind":"purchase","acquired":true,"shares":5000,"price":0.993,"value":4965.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9926 to $0.9950, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":76373,"source":{"system":"sec-edgar","filing":"0001213900-20-041228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020041228/ownership.xml","form_type":"4"}},{"id":3008321,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-10-13T17:01:27.000Z","date":"2020-10-12","kind":"grant","acquired":true,"shares":18466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 12, 2020, Reporting Person was granted 18,466 shares of Common Stock as compensation for Reporting Persons service as a director during the third quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":71373,"source":{"system":"sec-edgar","filing":"0001213900-20-031104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020031104/ownership.xml","form_type":"4"}},{"id":3084387,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-07-13T16:16:11.000Z","date":"2020-07-10","kind":"grant","acquired":true,"shares":14600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 10, 2020, Reporting Person was granted 14,600 shares of Common Stock as compensation for Reporting Persons service as a director during the second quarter of 2020, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."}],"balance_after":52907,"source":{"system":"sec-edgar","filing":"0001213900-20-017338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020017338/ownership.xml","form_type":"4"}},{"id":3136944,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2020-05-22T15:00:19.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":40500,"derivative":{"exercise_price":7.3,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001209191-20-031663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919120031663/doc4.xml","form_type":"4"}},{"id":3284633,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Warrants (right to buy)","published_at":"2020-02-07T16:32:58.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":2019,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By NSH 2008 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"Reporting Person is a co-trustee and beneficiary of the NSH 2008 Family Trust. The securities were acquired from OMV II and OMCP, pursuant to OMV II and OMCP distributions of all of their securities of Issuer on a pro rata basis to their members, for no consideration, on 12/31/2019. In prior reports, Reporting Person reported indirect beneficial ownership of a warrant to purchase 106,980 shares of Issuer Common Stock held by OMV II and a warrant to purchase 115,997 shares of Issuer Common Stock held by OMCP."}],"balance_after":2019,"derivative":{"exercise_price":5,"exercise_date":"2018-08-15","expiration_date":"2023-02-16","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":2019},"source":{"system":"sec-edgar","filing":"0001213900-20-002925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002925/ownership.xml","form_type":"4"}},{"id":3284632,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Warrants (right to buy)","published_at":"2020-02-07T16:32:58.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":1766,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By NSH 2008 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Reporting Person is a co-trustee and beneficiary of the NSH 2008 Family Trust. The securities were acquired from OMV II and OMCP, pursuant to OMV II and OMCP distributions of all of their securities of Issuer on a pro rata basis to their members, for no consideration, on 12/31/2019. In prior reports, Reporting Person reported indirect beneficial ownership of a warrant to purchase 108,838 shares of Issuer Common Stock held by OMV II and a warrant to purchase 69,139 shares of Issuer Common Stock held by OMCP."}],"balance_after":1766,"derivative":{"exercise_price":5,"exercise_date":"2016-12-22","expiration_date":"2021-12-22","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":1766},"source":{"system":"sec-edgar","filing":"0001213900-20-002925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002925/ownership.xml","form_type":"4"}},{"id":3284631,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Warrants (right to buy)","published_at":"2020-02-07T16:32:58.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The securities were acquired from OMV II, pursuant to OMV II's distribution of all of its securities of Issuer on a pro rata basis to its members, for no consideration, on 12/31/2019. In prior reports, Reporting Person reported indirect beneficial ownership of a warrant to purchase 106,980 shares of Issuer Common Stock held by OMV II."}],"balance_after":599,"derivative":{"exercise_price":5,"exercise_date":"2018-08-15","expiration_date":"2023-02-16","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":299},"source":{"system":"sec-edgar","filing":"0001213900-20-002925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002925/ownership.xml","form_type":"4"}},{"id":3284630,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Warrants (right to buy)","published_at":"2020-02-07T16:32:58.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The securities were acquired from OMV II, pursuant to OMV II's distribution of all of its securities of Issuer on a pro rata basis to its members, for no consideration, on 12/31/2019. In prior reports, Reporting Person reported indirect beneficial ownership of a warrant to purchase 108,838 shares of Issuer Common Stock held by OMV II."}],"balance_after":305,"derivative":{"exercise_price":5,"exercise_date":"2016-12-22","expiration_date":"2021-12-22","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":305},"source":{"system":"sec-edgar","filing":"0001213900-20-002925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002925/ownership.xml","form_type":"4"}},{"id":3284629,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T16:32:58.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option award was made in accordance with the terms of the 2016 Plan. The option becomes exercisable as to 50% of the shares on February 6, 2021, and the remaining shares will become exercisable on February 6, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":20000,"derivative":{"exercise_price":2.16,"expiration_date":"2030-02-06","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-20-002925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002925/ownership.xml","form_type":"4"}},{"id":3284628,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2020-02-07T16:32:58.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 6, 2020, Reporting Person was granted 20,000 Common Stock restricted stock units. The restricted stock units vest as to 50% of the shares on February 6, 2021, and the remaining restricted stock unit shares vest on February 6, 2022. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 307 shares received from Orchestra Medical Ventures II, L.P. (\"OMV II\"), pursuant to OMV II's distribution of all of its securities of Issuer on a pro rata basis to its members, for no consideration, on 12/31/2019. In prior reports, Reporting Person reported indirect beneficial ownership of 109,792 shares of Issuer Common Stock held by OMV II. In prior reports, Reporting Person also reported indirect beneficial ownership of 83,352 shares of Issuer Common Stock held by Orchestra Medical Ventures II Reserve, L.P. (\"OMV Reserve\"). OMV Reserve distributed all of its securities of Issuer on a pro rata basis to its members, for no consideration, on 12/31/2019 and Reporting Person retained no direct or indirect beneficial ownership of any shares of Issuer Common Stock pursuant to such pro rata distributions."}],"balance_after":38307,"source":{"system":"sec-edgar","filing":"0001213900-20-002925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390020002925/ownership.xml","form_type":"4"}},{"id":3474780,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2019-07-01T16:05:34.000Z","date":"2019-07-01","kind":"purchase","acquired":true,"shares":10000,"price":3,"value":30000.0,"ownership":{"direct":false,"nature":"By DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 1, 2019."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001213900-19-011860","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000121390019011860/ownership.xml","form_type":"4"}},{"id":3475959,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2019-06-28T16:03:17.000Z","date":"2019-05-22","kind":"grant","acquired":true,"shares":33300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":33300,"derivative":{"exercise_price":7.31,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":33300},"source":{"system":"sec-edgar","filing":"0001209191-19-039463","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919119039463/doc4.xml","form_type":"4"}},{"id":3590272,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-18T09:46:47.000Z","date":"2019-03-15","kind":"purchase","acquired":true,"shares":2000,"price":6.9788,"value":13957.6,"ownership":{"direct":false,"nature":"By DPH 2008 Trust"},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-19-019885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919119019885/doc4.xml","form_type":"4"}},{"id":3653853,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-15T17:00:42.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the \"2016 Plan\"). The option becomes exercisable as to 50% of the shares on February 13, 2020, and the remaining shares will become exercisable on February 13, 2021. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan."}],"balance_after":40000,"derivative":{"exercise_price":4.3,"expiration_date":"2029-02-13","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001615774-19-002638","document":"s116116_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577419002638/s116116_form4.xml","form_type":"4"}},{"id":3719093,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-12-26T17:14:18.000Z","date":"2018-12-24","kind":"purchase","acquired":true,"shares":20000,"price":2.7,"value":54000.0,"ownership":{"direct":false,"nature":"By DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on December 24, 2018."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001615774-18-014984","document":"s114872_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577418014984/s114872_form4.xml","form_type":"4"}},{"id":3754744,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-11-21T10:23:57.000Z","date":"2018-11-16","kind":"purchase","acquired":true,"shares":15000,"price":3.49,"value":52350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.60, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001615774-18-013100","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577418013100/ownership.xml","form_type":"4"}},{"id":3908553,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-06-04T16:30:51.000Z","date":"2018-05-31","kind":"other","acquired":true,"shares":2000000,"ownership":{"direct":false,"nature":"By Orchestra BioMed, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The securities are directly held by OBIO. Reporting Person, Mr. Sherman and Geoffrey W. Smith are the directors of OBIO. OBIO exchanged 2,000,000 shares of Series A Preferred Stock of OBIO in return for (a) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from OMV II and (b) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from Ascent Biomedical Ventures II, L.P."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The securities are directly held by OBIO. Reporting Person, Mr. Sherman and Geoffrey W. Smith are the directors of OBIO. OBIO exchanged 2,000,000 shares of Series A Preferred Stock of OBIO in return for (a) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from OMV II and (b) 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. from Ascent Biomedical Ventures II, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are directly held by OBIO. Reporting Person, Mr. Sherman and Mr. Smith are the directors of OBIO. Reporting Person, Mr. Sherman and Mr. Smith jointly exercise dispositive and voting power over the shares owned by OBIO. Each of Reporting Person, Mr. Sherman and Mr. Smith disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of their indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or Mr. Smith are the beneficial owners of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":2000000,"source":{"system":"sec-edgar","filing":"0001615774-18-004820","document":"s110579_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577418004820/s110579_form4.xml","form_type":"4"}},{"id":3908552,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-06-04T16:30:51.000Z","date":"2018-05-31","kind":"other","acquired":false,"shares":1000000,"ownership":{"direct":false,"nature":"By Orchestra Medical Ventures II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The securities are directly held by Orchestra Medical Ventures II, L.P. (\"OMV II\"). Orchestra Medical Ventures II GP, LLC (\"OMV GP\") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. OMV II exchanged 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. in return for 1,000,000 shares of Series A Preferred Stock of Orchestra BioMed, Inc., a Delaware corporation (\"OBIO\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The securities are directly held by Orchestra Medical Ventures II, L.P. (\"OMV II\"). Orchestra Medical Ventures II GP, LLC (\"OMV GP\") serves as general partner to OMV II. Reporting Person and Darren Sherman are the managing members of OMV GP. OMV II exchanged 1,000,000 shares of Common Stock of Motus GI Holdings, Inc. in return for 1,000,000 shares of Series A Preferred Stock of Orchestra BioMed, Inc., a Delaware corporation (\"OBIO\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by OMV II. OMV GP serves as general partner to OMV II. Reporting Person and Mr. Sherman are the managing members of OMV GP. Reporting Person and Mr. Sherman jointly exercise dispositive and voting power over the shares owned by OMV II. Each of Reporting Person, Mr. Sherman and OMV GP disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 (\"Section 16\"), beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Reporting Person, Mr. Sherman or OMV GP is the beneficial owner of such securities for purposes of Section 16 or for any other purposes."}],"balance_after":109792,"source":{"system":"sec-edgar","filing":"0001615774-18-004820","document":"s110579_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577418004820/s110579_form4.xml","form_type":"4"}},{"id":3915252,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option(right to buy)","published_at":"2018-05-29T16:08:43.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant."}],"balance_after":34000,"derivative":{"exercise_price":5.93,"expiration_date":"2028-05-24","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-18-033770","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919118033770/doc4.xml","form_type":"4"}},{"id":3915251,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T16:08:43.000Z","date":"2018-05-24","kind":"gift","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By SHA 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is a co-trustee of each of the NSH 2008 Family Trust, of which the reporting person is a beneficiary, the DPH 2008 Trust, of which the reporting person is a beneficiary, and the SHA 2008 Trust, of which the reporting person's sister is a beneficiary. On May 24, 2018, the co-trustees of the NSH 2008 Family Trust caused all of the shares of Common Stock of Corbus Pharmaceuticals Holdings, Inc. (the \"Company\") then held in the name of such trust to be transferred in equal portions to the DPH 2008 Trust and the SHA 2008 Trust, in accordance with the Trust Agreement Establishing NSH 2008 Family Trust, dated May 1, 2008."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 15, 2018, the reporting person filed a Form 4 which inadvertently reported that a purchase of 5,000 shares of Common Stock was made for the account of the NSH 2008 Family Trust. In fact, such purchase was made for the account of the DPH 2008 Trust. Accordingly, Column 5 of Table I of this Form 4 reflects that, as of immediately prior to the transactions reported hereby, 220,000 shares were held in the name of the NSH 2008 Family Trust and 10,000 shares were held in the name of the DPH 2008 Trust."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001209191-18-033770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919118033770/doc4.xml","form_type":"4"}},{"id":3915250,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T16:08:43.000Z","date":"2018-05-24","kind":"gift","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By DPH 2008 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is a co-trustee of each of the NSH 2008 Family Trust, of which the reporting person is a beneficiary, the DPH 2008 Trust, of which the reporting person is a beneficiary, and the SHA 2008 Trust, of which the reporting person's sister is a beneficiary. On May 24, 2018, the co-trustees of the NSH 2008 Family Trust caused all of the shares of Common Stock of Corbus Pharmaceuticals Holdings, Inc. (the \"Company\") then held in the name of such trust to be transferred in equal portions to the DPH 2008 Trust and the SHA 2008 Trust, in accordance with the Trust Agreement Establishing NSH 2008 Family Trust, dated May 1, 2008."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 15, 2018, the reporting person filed a Form 4 which inadvertently reported that a purchase of 5,000 shares of Common Stock was made for the account of the NSH 2008 Family Trust. In fact, such purchase was made for the account of the DPH 2008 Trust. Accordingly, Column 5 of Table I of this Form 4 reflects that, as of immediately prior to the transactions reported hereby, 220,000 shares were held in the name of the NSH 2008 Family Trust and 10,000 shares were held in the name of the DPH 2008 Trust."}],"balance_after":120000,"source":{"system":"sec-edgar","filing":"0001209191-18-033770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919118033770/doc4.xml","form_type":"4"}},{"id":3915249,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T16:08:43.000Z","date":"2018-05-24","kind":"gift","acquired":false,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By NSH 2008 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is a co-trustee of each of the NSH 2008 Family Trust, of which the reporting person is a beneficiary, the DPH 2008 Trust, of which the reporting person is a beneficiary, and the SHA 2008 Trust, of which the reporting person's sister is a beneficiary. On May 24, 2018, the co-trustees of the NSH 2008 Family Trust caused all of the shares of Common Stock of Corbus Pharmaceuticals Holdings, Inc. (the \"Company\") then held in the name of such trust to be transferred in equal portions to the DPH 2008 Trust and the SHA 2008 Trust, in accordance with the Trust Agreement Establishing NSH 2008 Family Trust, dated May 1, 2008."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 15, 2018, the reporting person filed a Form 4 which inadvertently reported that a purchase of 5,000 shares of Common Stock was made for the account of the NSH 2008 Family Trust. In fact, such purchase was made for the account of the DPH 2008 Trust. Accordingly, Column 5 of Table I of this Form 4 reflects that, as of immediately prior to the transactions reported hereby, 220,000 shares were held in the name of the NSH 2008 Family Trust and 10,000 shares were held in the name of the DPH 2008 Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-033770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919118033770/doc4.xml","form_type":"4"}},{"id":3924123,"issuer":{"id":93100,"kind":"organization","name":"Motus GI Holdings, Inc.","symbol":"MOTS"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Chairman of the Board"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2018-05-21T08:02:36.000Z","date":"2018-05-17","kind":"purchase","acquired":true,"shares":5000,"price":5.49,"value":27450.0,"ownership":{"direct":false,"nature":"By DPH 2008 Trust"},"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001615774-18-004110","document":"s110297_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1686850/000161577418004110/s110297_4.xml","form_type":"4"}},{"id":3932698,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-15T14:07:16.000Z","date":"2018-05-14","kind":"purchase","acquired":true,"shares":5000,"price":5.475,"value":27375.0,"ownership":{"direct":false,"nature":"By DPH 2008 Trust"},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-18-030144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919118030144/doc4.xml","form_type":"4"}},{"id":3994449,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":38782,"kind":"person","name":"Hochman David P","position":1,"cik":"0001292834","reported_name":"Hochman David P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-15T10:42:34.000Z","date":"2018-03-14","kind":"purchase","acquired":true,"shares":5000,"price":6.665,"value":33325.0,"ownership":{"direct":false,"nature":"By NSH 2008 Family Trust"},"balance_after":225000,"source":{"system":"sec-edgar","filing":"0001209191-18-019763","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1292834/000120919118019763/doc4.xml","form_type":"4"}}],"next_cursor":"2018-03-15T10:42:34.000000Z,3994449"}